• Perguntas frequentes
  • Glossário
Fechar

Perguntas frequentes

Why are animal models used when testing the safety of a new therapy?
What role do preclinical and clinical trials play in ensuring patient safety?
Why are some conditions more suitable for gene and cell therapies than others?
There is an approved treatment available for my condition - why can't I receive it?
How to look for approved medicines?
How are medicines developed and approved?

Ver todas as FAQs

Fechar

Glossário

Accelerated assessment
Adeno-associated virus (AAV)
Adenovirus
Adult stem cells
Advanced Therapy Investigational Medicinal Product (ATIMP)
Advanced Therapy Medicinal Product (ATMP)
Advertising 
Antibody
Antigen
Base editors

Ver o glossário completo

Voltar ao índice do glossário

Conditional Marketing Authorisation

Specific temporary (one year renewable) approval for certain medicines targeting an unmet medical need.

 

Read related content in the entry on Conditional marketing authorisation of the research pathways.

Voltar ao topo
Achou o conteúdo desta página útil? Se não, pode deixar-nos uma mensagem para que possamos melhorar Envie-nos as suas ideias